Johnson & Johnson (JNJ)
Healthcare – PHARMACEUTICAL PREPARATIONS
- CEO
- Joaquin Duato
- Headquarters
- United States
- Employees
- 140,800
- Market Cap
- $639.9B
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
SentiSense also tracks daily options readings for Johnson & Johnson: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Johnson & Johnson stock analysis, sentiment tracking, and market intelligence on SentiSense.